<DOC>
	<DOCNO>NCT00446329</DOCNO>
	<brief_summary>The 1st phase study ass acute biochemical response PTH , calcium phosphorus orally administer dos cinacalcet ( 60mg ) twice ( 30mg x 2 ) per day . The 2nd phase study design evaluate long term effect cinacalcet BMD ( bone mineral density ) level PTH , calcium , phosphorus well ability control secondary hyperparathyroidism without simultaneous administration vitamin D compound .</brief_summary>
	<brief_title>Cinacalcet Secondary Hyperparathyroidism Patients Receiving Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Age old 18 yr On hemodialysis least 3 month ( thrice weekly ) iPTH &gt; 300pg/ml histological evidence secondary hyperparathyroidism Calcium &gt; 8.1 mg/dl Unstable clinical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>